13 May 2015

2014 Annual Report and Accounts and Notice of AGM

Verona Pharma plc

Read more

12 May 2015

Final Results

VERONA PHARMA PLC - Final Results

Read more

5 May 2015

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

14 April 2015

Presentation at the Asthma and COPD Conference

VERONA PHARMA PLC - Presentation at the Asthma and COPD Conference

Read more

23 March 2015

Interim results from new RPL554 trial

VERONA PHARMA PLC - Interim results from new RPL554 trial

Read more

3 March 2015

Trading and Development Programme Update

VERONA PHARMA PLC - Trading and Development Programme Update

Read more

3 March 2015

Director’s Dealing

VERONA PHARMA PLC - Director’s Dealing

Read more

16 February 2015

Director's Dealing

Verona Pharma plc

Read more

5 February 2015

Director’s Dealing

VERONA PHARMA PLC - Director’s Dealing

Read more

30 January 2015

Grant of Share Options

VERONA PHARMA PLC - Grant of Share Options

Read more

Targeting unmet needs

384m people worldwide suffer from COPD and 37 years is the median life expectancy of CF patients

Read more about COPD and CF in the unmet needs section of this website

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us